Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

idiopathic multicentric Castleman disease News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

HHV8-associated multicentric Castleman disease with Kaposi sarcoma in an immunocompetent patient: a case report and review of the literature.

A recent study analyzed the morbidity burden and healthcare costs associated with idiopathic multicentric Castleman disease (iMCD). The retrospective cohort analysis provides valuable insights into the economic impact of this rare disease.

A recent study highlights that pediatric idiopathic multicentric Castleman disease often presents with severe symptoms but shows responsiveness to treatment with siltuximab. This finding underscores the potential for effective management of this rare condition in children.

A new study outlines the development and validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS). This international mixed methods study aims to enhance understanding of symptom burden in patients with idiopathic multicentric Castleman disease.

A recent study explores HIV-negative KSHV/HHV8-associated multicentric Castleman disease, highlighting its concurrent occurrence with Kaposi sarcoma and POEMS-like manifestations. This research adds to the understanding of complex interactions in rare diseases.

A study highlights the significance of serum interleukin-6 (IL-6) monitoring in patients with idiopathic multicentric Castleman disease undergoing non-anti-IL-6 therapy. This research underscores the potential for IL-6 levels to inform treatment decisions and patient management.

A recent study highlights a case of idiopathic multicentric Castleman disease manifesting as recurrent acute-onset demyelinating neuropathy. This research contributes to the understanding of the disease's neurological presentations.

A case report details the angiomatous subtype of penile Kaposi sarcoma occurring alongside HIV-negative multicentric Castleman disease. This study contributes to the understanding of the complex interplay between these rare conditions.

A recent study published in PubMed explores interfollicular plasmacytosis and hyperplastic germinal centers in idiopathic multicentric Castleman disease and idiopathic plasmacytic lymphadenopathy subtype. This research may provide insights into the underlying mechanisms of these rare conditions.

A recent publication explores the histopathological grading of idiopathic multicentric Castleman disease, providing insights from a pathologist's perspective. This research aims to enhance understanding of the disease's complexities and improve diagnostic accuracy.

A case study reports successful treatment of severe polyneuropathy in a patient with HIV-negative human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin. This finding may inform future therapeutic strategies for similar cases.

A recent study highlights successful bilateral lung transplantation in a patient with multicentric Castleman disease, demonstrating long-term survival despite severe pulmonary involvement. This case adds to the understanding of treatment options for this rare disease.

Not rare diseases news,news about your rare disease.